AstraZeneca PLC (STO:AZN)
1,322.00
-14.50 (-1.08%)
May 13, 2025, 5:29 PM CET
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
5.85M SEK
Profits / Employee
827.29K SEK
Market Cap
2,040.02B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,204 |
Getinge AB | 11,791 |
Camurus AB | 256 |
Medicover AB | 47,256 |
AddLife AB | 2,181 |
Vitrolife AB | 1,169 |
Vimian Group AB | 1,200 |
AstraZeneca News
- 17 hours ago - AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025 - Business Wire
- 1 day ago - AstraZeneca and GSK in the firing line as Trump targets big pharma: ALEX BRUMMER - This is Money
- 1 day ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ
- 1 day ago - Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%' - The Guardian
- 2 days ago - AstraZeneca (AZN) Faces Market Uncertainty Amid Drug Pricing Changes | AZN Stock News - GuruFocus
- 4 days ago - AstraZeneca's bladder cancer treatment shows positive results in trial - Seeking Alpha
- 4 days ago - IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial - Business Wire
- 6 days ago - AstraZeneca, Daiichi post late-stage trial win for Enhertu in early-stage breast cancer - Seeking Alpha